These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20633470)

  • 1. Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development.
    Fuxe K; Marcellino D; Guidolin D; Woods AS; Agnati L
    J Acupunct Meridian Stud; 2009 Mar; 2(1):1-25. PubMed ID: 20633470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions.
    Fuxe K; Marcellino D; Borroto-Escuela DO; Frankowska M; Ferraro L; Guidolin D; Ciruela F; Agnati LF
    J Recept Signal Transduct Res; 2010 Oct; 30(5):272-83. PubMed ID: 20684666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.
    Fuxe K; Canals M; Torvinen M; Marcellino D; Terasmaa A; Genedani S; Leo G; Guidolin D; Diaz-Cabiale Z; Rivera A; Lundstrom L; Langel U; Narvaez J; Tanganelli S; Lluis C; Ferré S; Woods A; Franco R; Agnati LF
    J Neural Transm (Vienna); 2007 Jan; 114(1):49-75. PubMed ID: 17066251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.
    Fuxe K; Marcellino D; Rivera A; Diaz-Cabiale Z; Filip M; Gago B; Roberts DC; Langel U; Genedani S; Ferraro L; de la Calle A; Narvaez J; Tanganelli S; Woods A; Agnati LF
    Brain Res Rev; 2008 Aug; 58(2):415-52. PubMed ID: 18222544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.
    Agnati LF; Ferré S; Lluis C; Franco R; Fuxe K
    Pharmacol Rev; 2003 Sep; 55(3):509-50. PubMed ID: 12869660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis.
    Fuxe K; Marcellino D; Leo G; Agnati LF
    Curr Opin Pharmacol; 2010 Feb; 10(1):14-22. PubMed ID: 19942481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-receptor interactions: A novel concept in brain integration.
    Agnati LF; Guidolin D; Leo G; Carone C; Genedani S; Fuxe K
    Prog Neurobiol; 2010 Feb; 90(2):157-75. PubMed ID: 19850102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How receptor mosaics decode transmitter signals. Possible relevance of cooperativity.
    Agnati LF; Fuxe K; Ferré S
    Trends Biochem Sci; 2005 Apr; 30(4):188-93. PubMed ID: 15817395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration.
    Borroto-Escuela DO; Tarakanov AO; Guidolin D; Ciruela F; Agnati LF; Fuxe K
    IUBMB Life; 2011 Jul; 63(7):463-72. PubMed ID: 21698749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPCR heteromers and their allosteric receptor-receptor interactions.
    Fuxe K; Borroto-Escuela DO; Marcellino D; Romero-Fernandez W; Frankowska M; Guidolin D; Filip M; Ferraro L; Woods AS; Tarakanov A; Ciruela F; Agnati LF; Tanganelli S
    Curr Med Chem; 2012; 19(3):356-63. PubMed ID: 22335512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases.
    Agnati LF; Ferre S; Burioni R; Woods A; Genedani S; Franco R; Fuxe K
    Neuromolecular Med; 2005; 7(1-2):61-78. PubMed ID: 16052039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple mathematical model of cooperativity in receptor mosaics based on the "symmetry rule".
    Agnati LF; Tarakanov AO; Guidolin D
    Biosystems; 2005 May; 80(2):165-73. PubMed ID: 15823415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimers and receptor mosaics of different types of G-protein-coupled receptors.
    Fuxe K; Marcellino D; Guidolin D; Woods AS; Agnati LF
    Physiology (Bethesda); 2008 Dec; 23():322-32. PubMed ID: 19074740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative action of receptor mosaics: relevance of receptor topology and allosteric modulators.
    Francesco AL; Diego G; Susanna G; Giuseppina L; Amina WS; Sergi F; Rafael F; Kjell F
    J Recept Signal Transduct Res; 2008; 28(6):543-65. PubMed ID: 19096975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering.
    Franco R; Canals M; Marcellino D; Ferré S; Agnati L; Mallol J; Casadó V; Ciruela F; Fuxe K; Lluis C; Canela EI
    Trends Biochem Sci; 2003 May; 28(5):238-43. PubMed ID: 12765835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical considerations on the topological organization of receptor mosaics.
    Francesco AL; Kjell F; Amina W; Susanna G; Diego G
    Curr Protein Pept Sci; 2009 Dec; 10(6):559-69. PubMed ID: 19751189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development.
    Agnati LF; Tarakanov AO; Ferré S; Fuxe K; Guidolin D
    J Mol Neurosci; 2005; 26(2-3):193-208. PubMed ID: 16012193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.
    Schelshorn D; Joly F; Mutel S; Hampe C; Breton B; Mutel V; Lütjens R
    Mol Pharmacol; 2012 Mar; 81(3):309-18. PubMed ID: 22108912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.